Baylor College of Medicine Adolescent Medicine Trials Unit

贝勒医学院青少年医学试验单位

• 批准号: 8811024
• 负责人: MARY E PAUL
• 金额: $ 42.27万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-07 至 2017-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8811024
• 关键词: AIDS prevention; AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Adherence; Adolescent; Adolescent Medicine; Adolescent Medicine Trials Network; Adolescent and Young Adult; Age-Years; Anti-Retroviral Agents; Antidepressive Agents; Area; Behavioral; Behavioral Research; Caring; Cities; Clinic; Clinic Visits; Clinical; Collaborations; Communities; County; Drug Kinetics; Enrollment; Event; HIV; HIV Infections; HIV-infected adolescents; Health; Home environment; Hypersensitivity; Immunology; Intervention; Intervention Trial; Lead; Medical; Medically Underserved Area; Medicine; Needs Assessment; Online Systems; Patients; Pediatric Hospitals; Pharmaceutical Preparations; Primary Prevention; Principal Investigator; Public Health; Publishing; Regimen; Request for Applications; Research; Research Personnel; Resources; Retrovirology; Risk; Risk Reduction; Safe Sex; Secondary Prevention; Structure; Technology; Teenagers; Testing; Texas; Therapeutic; Therapeutic Trials; United States; Youth; antiretroviral therapy; base; behavioral study; clinical research site; college; community organizations; design; experience; improved; innovation; interactive multimedia; meetings; outreach; pediatric department; programs; psychosocial; research study; response; sexually active; skills training; tertiary prevention; theories; therapy adherence; transmission process; trial design

DESCRIPTION (provided by applicant): Baylor College of Medicine (BCM) is applying for an Adolescent Medicine Trials Unit (ATU) in response to NIH RFA-HD-10-015 Adolescent Medicine Trials Network for HIV/AIDS Interventions. The BCM Trials Unit plans to contribute to the ATN's research agenda by providing an experienced research team to plan, enroll, analyze and publish results of research trials including behavioral research studies, community needs assessments, and therapeutic trials while meeting clinical and behavioral needs of HIV-infected youth. The BCM ATU will have three resources of patients: 1) Teen Clinics for HIV-infected youth at Texas Children's Hospital (TCH) lead by Drs Paul and Schwarzwald, Sections of Allergy and Immunology, and Retrovirology respectively, Department of Pediatrics, BCM; 2) Thomas Street Clinic (TSC) HIV-infected youth clinic lead by Dr Schwarzwald; and 3) Project Medical Home Clinics which provide adolescent care in medically underserved areas of Houston lead by Dr Desiree Evans, Department of Pediatrics, BCM. BCM will have 225 HIV-infected adolescents and over 1000 at-risk adolescents who are 12-24 years of age available to approach for enrollment into intervention trials aimed at the prevention of HIV, primary prevention In at-risk and secondary and tertiary prevention in the HIV-infected, pre-adolescents, adolescents, and young adults. BCM proposes unique studies involving innovative use of technology for secondary prevention of HIV transmission and adherence to HIV medication regimens among youth, a study of the pharmacokinetics to evaluate interactions of antidepressants when used with antiretroviral medications in HIV-infected youth, and a study that evaluates linkage to care for youth identified as HIV-infected through a large, youth oriented community testing event sponsored by the city health department and a community based AIDS organization. BCM ATU has the clinical, behavioral and research capacities and linkages to community to participate in multiple trials aimed at prevention of HIV in youth and trials aimed at improvements in management and psychosocial functioning of HIV-infected youth. RELEVANCE: Youth in Houston and surrounding counties have one of the fastest growing rates of HIV-infection in the United States. Baylor College of Medicine (BCM)'s application to become an Adolescent Medicine Trials Unit is relevant to public health in that BCM plans to implement trials designed to promote primary prevention in HIV at-risk and secondary and tertiary prevention in HIV-infected youth.

描述（由申请人提供）：贝勒医学院（Baylor College of Medicine）正在申请青少年医学试验单位（ATU），以响应NIH RFA-HD-10-015青少年医学试验网络的艾滋病毒/艾滋病干预措施。艾滋病试验股计划通过提供一个经验丰富的研究小组来规划、登记、分析和发表研究试验的结果，包括行为研究、社区需求评估和治疗试验，同时满足艾滋病毒感染青年的临床和行为需求，从而为艾滋病网络的研究议程做出贡献。该中心将有三个病人资源：1）德克萨斯州儿童医院（TCH）的艾滋病毒感染青少年诊所，分别由德克萨斯州儿科过敏和免疫科以及逆转录病毒科的Paul和Schwarzwald博士领导; 2）托马斯街诊所（TSC）艾滋病毒感染青少年诊所，由Schwarzwald博士领导;和3）项目医疗家庭诊所，提供青少年护理在医疗服务不足的地区休斯顿博士领导的德西里埃文斯，儿科系，堪萨斯州。该中心将有225名艾滋病毒感染青少年和1000多名12-24岁的高危青少年可供参加旨在预防艾滋病毒、高危人群的一级预防以及艾滋病毒感染、青春期前、青少年和年轻人的二级和三级预防的干预试验。联合国艾滋病毒/艾滋病联合规划署提出了一些独特的研究，涉及创新性地使用技术来进行艾滋病毒传播的二级预防和青年人坚持艾滋病毒药物治疗方案，一项药物动力学研究，以评估抗抑郁药与抗逆转录病毒药物在感染艾滋病毒的青年人中的相互作用，以及一项研究，通过一个大型的、由市卫生部门和一个社区艾滋病组织主办的面向青年的社区检测活动。该中心具有临床、行为和研究能力，并与社区建立联系，参与旨在预防青年艾滋病毒的多项试验，以及旨在改善艾滋病毒感染青年的管理和心理社会功能的试验。 相关性：休斯顿和周边县的青年是美国艾滋病毒感染率增长最快的地区之一。贝勒医学院申请成为青少年医学试验单位与公共卫生有关，因为贝勒医学院计划实施旨在促进艾滋病毒高危人群的初级预防和艾滋病毒感染青年的二级和三级预防的试验。